Fifty-one of the 112 approvals for abbreviated new drug applications (ANDA) given by the USFDA went to India. Further, Indian companies received 6 tentative approvals from an aggregate of 23 tentative approvals in the Jan-March quarter of 2018. With eleven ANDA approvals, Aurobindo Pharma received the highest number among the...
Purdue Partners with Dr. Reddy’s Laboratories in India for R&D
Purdue University has signed a memorandum of understanding with Dr. Reddy's Laboratories Limited, Hyderabad, India, to strengthen pharmaceutical research and development. The intent is to forge a strong strategic partnership in a range of research areas and novel technologies. Areas of planned collaborative research and education include targeted drug delivery,...
India’s Dr. Reddy’s Lab Strategizes for the U.S. Market
Financial Express reports that India's Dr. Reddy's Laboratories, based in the southern city of Hyderabad, disclosed plans to expand in the U.S. and emerging markets this year; widen its reach in Europe; invest in new drugs that offer higher margins such as complex generics, biosimilars and proprietary products; and promote...